Wordt geladen...
IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis
BACKGROUND: IL-17A has recently emerged as a potential target that regulates the extensive inflammation and abnormal bone formation observed in ankylosing spondylitis (AS). Blocking IL-17A is expected to inhibit bony ankylosis. Here, we investigated the effects of anti IL-17A agents in AS. METHODS:...
Bewaard in:
| Gepubliceerd in: | Arthritis Res Ther |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5992730/ https://ncbi.nlm.nih.gov/pubmed/29880011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-018-1582-3 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|